These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 626988)

  • 1. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
    Pratesi G; Casazza AM; Di Marco A
    Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
    Israel M; Modest EJ; Frei E
    Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antineoplastic activity of adriamycin and N-trifluoroacetyladriamycin-14-valerate.
    Vecchi A; Cairo M; Mantovani A; Sironi M; Spreafico F
    Cancer Treat Rep; 1978 Jan; 62(1):111-7. PubMed ID: 626989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies.
    Parker LM; Hirst M; Israel M
    Cancer Treat Rep; 1978 Jan; 62(1):119-27. PubMed ID: 272230
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of Tween 80 on adriamycin cytotoxicity in murine P388 leukemia.
    Chitnis MP; Menon RS; Gude RP
    Tumori; 1984 Aug; 70(4):313-5. PubMed ID: 6474580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.
    Di Marco A; Casazza AM; Giuliani F; Pratesi G; Arcamone F; Bernardi L; Franchi G; Giardino P; Patelli B; Penco S
    Cancer Treat Rep; 1978 Mar; 62(3):375-80. PubMed ID: 647696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the antitumor activity of adriamycin by Tween 80.
    Casazza AM; Pratesi G; Giuliani F; Formelli F; Di Marco A
    Tumori; 1978 Apr; 64(2):115-29. PubMed ID: 675847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor activity of adriamycin].
    Kitaura K; Watanabe Y; Ishihara Y; Takahira H
    Jpn J Antibiot; 1972 Apr; 25(2):65-71. PubMed ID: 4341940
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog.
    Blum RH; Garnick MB; Israel M; Canellos GP; Henderson IC; Frei E
    Cancer Treat Rep; 1979 May; 63(5):919-23. PubMed ID: 455334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of 4-demethoxydaunorubicin administered orally.
    Di Marco A; Casazza AM; Pratesi G
    Cancer Treat Rep; 1977 Aug; 61(5):893-4. PubMed ID: 890695
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T; Suzuki K; Sakakibara S; Komuro K; Nagasawa M; Takeuchi T; Umezawa H
    Jpn J Cancer Res; 1985 Oct; 76(10):1008-20. PubMed ID: 3935619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin analogues. rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives.
    Israel M; Potti PG; Seshadri R
    J Med Chem; 1985 Sep; 28(9):1223-8. PubMed ID: 3839851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of a water-insoluble compound entrapped in liposomes on L1210 leukemia in mice.
    Brassinne C; Atassi G; Frühling J; Penasse W; Coune A; Hildebrand J; Ruysschaert JM; Laduron C
    J Natl Cancer Inst; 1983 Jun; 70(6):1081-6. PubMed ID: 6574278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
    McGovren JP
    Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
    Marks TA; Venditti JM
    Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
    Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.